載入...
Combined VEGFR and MAPK pathway inhibition in angiosarcoma
Angiosarcoma is an aggressive malignancy of endothelial cells that carries a high mortality rate. Cytotoxic chemotherapy can elicit clinical responses, but the duration of response is limited. Sequencing reveals multiple mutations in angiogenesis pathways in angiosarcomas, particularly in vascular e...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087824/ https://ncbi.nlm.nih.gov/pubmed/33931674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88703-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|